MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
NCT ID: NCT05194254
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
68 participants
INTERVENTIONAL
2022-01-04
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Understanding the Mechanisms of Autism : an MRI and Social Cognition Study
NCT06334588
Development of Eye-tracking Based Markers for Autism in Young Children
NCT03286621
Autism Spectrum Disorders: Double Blind Randomized Placebo-control Active Pilot Study of Transcranial Magnetic Stimulation Applied to the Superior Temporal Sulcus
NCT04442061
Brain Plasticity of Autism in Response to Early Behavioral Intervention: A Multimodal MRI Study
NCT02807766
Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder
NCT02573428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ASD
people with Autism Spectrum Disorders
MRI-ET
coupled fMRI and Eye Tracking tools
TD
Typical Development) group of people
MRI-ET
coupled fMRI and Eye Tracking tools
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI-ET
coupled fMRI and Eye Tracking tools
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 10 to 20 years old
* Diagnosis of ASD (CARS) ≥ 30 performed at inclusion
* IQ test evaluation (regardless of the result) performed by a trained psychologist
* Obtaining informed oral and written consent after appropriate information
* Obtaining informed oral and written consent from the legal guardian after information
* Be affiliated with social security
* No contraindication to magnetic resonance imaging
For the TD (Typical Development) group of people (control group):
* Age between 10 to 20 years old
* Diagnosis of ASD (CARS) \<30 performed at inclusion
* IQ test evaluation (regardless of the result) performed by a trained psychologist
* Obtaining informed oral and written consent after appropriate information
* Obtaining informed oral and written consent from the legal guardian after information
* Be affiliated with social security
* No contraindication to magnetic resonance imaging
Exclusion Criteria
* Age outside the range 10 to 20 years
* Person with a contraindication to MRI (including claustrophobia, pace maker, neurosurgical clips, vascular clips, heart valves, ventriculoperitoneal valves, cochlear implant, neurostimulator, intraocular metal shards, joint prosthesis, etc.)
* Person suffering from major obesity (\> 140 kg) not allowing him to enter the tunnel of the MRI machine (diameter \<70cm)
* Pregnant or breastfeeding woman
* Person under guardianship or guardianship or deprived of liberty by a judicial or administrative decision
For TD people (control group):
* Person with psychiatric disorders such as attention disorder with or without hyperactivity, depression, bipolar disorder and schizophrenia.
* Person with a neurological history such as epilepsy and / or neurovascular accident.
10 Years
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Picardie
Amiens, Picardie, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2021_843_0194
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.